Wells Fargo’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-94,674
| Closed | -$8.52K | – | 7282 |
|
2023
Q2 | $8.52K | Hold |
94,674
| – | – | ﹤0.01% | 5640 |
|
2023
Q1 | $5.21K | Hold |
94,674
| – | – | ﹤0.01% | 5724 |
|
2022
Q4 | $4.32K | Hold |
94,674
| – | – | ﹤0.01% | 5492 |
|
2022
Q3 | $6K | Hold |
94,674
| – | – | ﹤0.01% | 5543 |
|
2022
Q2 | $14K | Hold |
94,674
| – | – | ﹤0.01% | 5333 |
|
2022
Q1 | $28K | Hold |
94,674
| – | – | ﹤0.01% | 5556 |
|
2021
Q4 | $48K | Hold |
94,674
| – | – | ﹤0.01% | 5531 |
|
2021
Q3 | $52K | Hold |
94,674
| – | – | ﹤0.01% | 5308 |
|
2021
Q2 | $90K | Buy |
+94,674
| New | +$90K | ﹤0.01% | 5021 |
|